ClinicalTrials.Veeva

Menu

Staphylococcus Lugdunensis Prosthetic Joint Infection

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Prosthetic Joint Infection
Staphylococcal Infections

Treatments

Other: Prothestic joint infection due to Staphylococcus lugdunensis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Staphylococcus lugdunensis is a coagulase-negative staphylococcus belonging to the human commensal cutaneous flora, and has been little studied in the field of prosthetic joint infections. However, it shares many virulence traits with Staphylococcus aureus, including many adhesins and its ability to form biofilm, and the few series of cases reports a significant failure rate.

Enrollment

84 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • infection of joint prosthesis (whatever its type) with Staphylococcus lugdunensis defined by the positivity of at least 2 gold-standard samples (joint puncture, intraoperative samples) with S. lugdunensis; OR
  • a single positive gold-standard sample or positive blood cultures AND formal clinical, radiological, biological and / or pathological arguments in favor of an infection of joint prosthesis AND absence of other pathogenic agent

Exclusion criteria

  • none

Trial design

84 participants in 1 patient group

Prothestic joint infection due to Staphylococcus lugdunensis
Description:
Patients having had a prosthetic joint infection with Staphylococcus lugdunensis
Treatment:
Other: Prothestic joint infection due to Staphylococcus lugdunensis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems